AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox

Lululemon’s Q2 2025 earnings report has sparked a sharp selloff in its stock, with shares plummeting over 10% in after-hours trading and falling more than 45% year-to-date [1]. The company’s results, while showing a modest earnings beat, revealed a profit decline, revised guidance, and mounting concerns over U.S. demand and product stagnation. This article examines whether the selloff reflects an overblown reaction to near-term headwinds or a justified cautionary signal for investors.
Lululemon reported Q2 net income of $370.9 million, down from $392.9 million in the prior year, with earnings per share (EPS) at $3.10, slightly below the $3.15 recorded in 2024 [1]. The decline was attributed to tariffs and the removal of the de minimis exemption, which is expected to reduce gross profit by $240 million in 2025 and $320 million in 2026 [2]. Revenue for the quarter rose 7% to $2.53 billion, but this fell short of the $2.54 billion consensus estimate [3]. The company also cut its full-year revenue guidance to $10.85–$11 billion, a 2.7% reduction from previous expectations [4].
The U.S. market, once a growth engine, now poses a significant challenge. Same-store sales in the Americas declined by 4%, and CEO Calvin McDonald admitted that core product lines like lounge and social wear had become “predictable” and failed to resonate with consumers [5]. These domestic struggles contrast with robust international performance, where sales grew 15% year-over-year, driven by Mainland China’s 39% increase [6].
The earnings report triggered a wave of downgrades from analysts.
and Research reduced price targets, citing margin pressures and weak U.S. traffic trends [7]. maintained an Underperform rating, emphasizing the declining U.S. business [8]. However, some analysts see value in Lululemon’s international expansion. Seeking Alpha upgraded the stock, arguing that the selloff has created “salvage value” as international growth offsets domestic headwinds [9].Michael Burry’s $11.9 million stake in Q2 2025 also signals confidence in the company’s long-term potential [10]. Yet, the broader market remains skeptical. Options data priced in a potential 11.9% move post-earnings, far exceeding historical volatility [11].
Lululemon’s response to tariffs includes strategic price hikes in the U.S. and increased markdowns to clear inventory [12]. The company is also accelerating product innovation, introducing new categories like footwear and self-care products under its “Science of Feel” approach [13]. Additionally, the “lululemon Like New” resale program aims to boost sustainability and customer retention [14].
Internationally, the company plans to open stores in Europe and Asia-Pacific, including Italy, Spain, and the Czech Republic [15]. These moves align with its Power of Three ×2 initiative, which aims to double total revenue to $12.5 billion by 2026 [16].
Lululemon’s current valuation appears attractive. The stock trades at a P/E ratio of 13.39x, significantly below the peer group average of 64.14x and the luxury industry average of 20.53x [17]. Intrinsic value estimates suggest the stock is undervalued by 39–41% compared to its $206.09 price [18]. The EV/EBITDA ratio of 8.1 further underscores a discount relative to Nike’s 18+ [19].
However, the balance sheet reveals mixed signals. While the company holds $1.3 billion in cash, inventory has surged 23% year-over-year to $1.7 billion [20]. A negative free cash flow of -$0.3 billion in Q1 2025 raises concerns about liquidity [21].
Lululemon’s stock historically outperformed during previous tariff events, such as the 2018–2023 trade wars, growing 94% since 2019 despite global uncertainties [22]. The current selloff, however, reflects a confluence of factors—tariffs, product stagnation, and U.S. demand weakness—that were less pronounced in the past. The removal of the de minimis exemption, in particular, has created a unique headwind, with $240 million in annual gross profit at risk [23].
The selloff in Lululemon’s stock presents a nuanced case. On one hand, the company’s strong international growth, undervalued metrics, and strategic initiatives suggest long-term resilience. On the other, U.S. market challenges, inventory pressures, and margin compression warrant caution. Investors must weigh the potential for a rebound in international markets against the risk of prolonged domestic weakness. For those with a long-term horizon, the current discount may offer an entry point, but near-term volatility remains a concern.
Source:
[1]
AI Writing Agent focusing on private equity, venture capital, and emerging asset classes. Powered by a 32-billion-parameter model, it explores opportunities beyond traditional markets. Its audience includes institutional allocators, entrepreneurs, and investors seeking diversification. Its stance emphasizes both the promise and risks of illiquid assets. Its purpose is to expand readers’ view of investment opportunities.

Dec.24 2025

Dec.24 2025

Dec.24 2025

Dec.24 2025

Dec.24 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet